Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
DL-Pyroglutamic acid is a cyclized form of glutamic acid that has been found in E. aureum and is a racemic mixture of the D-glutamate metabolite D-pyroglutamic acid (Item No. 31170) and the L-glutamate and L-glutamine metabolite L-pyroglutamic acid (Item No. 36531).1 A DL-pyroglutamic acid-magnesium complex decreases immobility time in the forced swim test and increases the latency to paw withdrawal in the hot plate test in rats.2 DL-Pyroglutamic acid has been used as a building block in the synthesis of GABA peptides with antinociceptive activity in rats.3 Plasma levels of D- and L-pyroglutamic acid are increased in patients with end-stage renal disease.4
WARNING This product is not for human or veterinary use.
1. Characterization of pyrrolidine alkaloids of Epipremnum aureum for their antitermite activity against subterranean termites with SEM studies. Proc. Natl. Acad. Sci. India Sect. B Biol. Sci. 89(1), 53-62 (2019).
2. Antidepressant and antinociceptive activities in animal models and in vitro assessment of the anti-
3. Synthesis and antinociceptive activity of GABA and pyroglutamic acid short peptides. Pharm. Chem. J. 56, 339–344 (2022).
4. Accumulation of 50oxo-